These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36287112)

  • 1. Microbiome and metabolome in inflammatory bowel disease.
    Upadhyay KG; Desai DC; Ashavaid TF; Dherai AJ
    J Gastroenterol Hepatol; 2023 Jan; 38(1):34-43. PubMed ID: 36287112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation.
    Wu R; Xiong R; Li Y; Chen J; Yan R
    J Autoimmun; 2023 Dec; 141():103062. PubMed ID: 37246133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
    Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
    Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
    Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of gut microbiome in inflammatory bowel disease diagnosis and prognosis.
    Zheng J; Sun Q; Zhang J; Ng SC
    United European Gastroenterol J; 2022 Dec; 10(10):1091-1102. PubMed ID: 36461896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J; Brislawn CJ; Lamendella R; Vázquez-Baeza Y; Walters WA; Bramer LM; D'Amato M; Bonfiglio F; McDonald D; Gonzalez A; McClure EE; Dunklebarger MF; Knight R; Jansson JK
    Nat Microbiol; 2017 Feb; 2():17004. PubMed ID: 28191884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Host Genetics and Intestinal Microbiota and Metabolome as a New Insight into IBD Pathogenesis.
    Zakerska-Banaszak O; Zuraszek-Szymanska J; Eder P; Ladziak K; Slomski R; Skrzypczak-Zielinska M
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. More on the interplay between gut microbiota, autophagy, and inflammatory bowel disease is needed.
    Subramanian A; Jahabardeen A; Thamaraikani T; Vellapandian C
    World J Gastroenterol; 2024 Jul; 30(27):3356-3360. PubMed ID: 39086745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
    Santana PT; Rosas SLB; Ribeiro BE; Marinho Y; de Souza HSP
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review.
    Recharla N; Geesala R; Shi XZ
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242159
    [No Abstract]   [Full Text] [Related]  

  • 11. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
    Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
    Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Faecal metabolome and its determinants in inflammatory bowel disease.
    Vich Vila A; Hu S; Andreu-Sánchez S; Collij V; Jansen BH; Augustijn HE; Bolte LA; Ruigrok RAAA; Abu-Ali G; Giallourakis C; Schneider J; Parkinson J; Al-Garawi A; Zhernakova A; Gacesa R; Fu J; Weersma RK
    Gut; 2023 Aug; 72(8):1472-1485. PubMed ID: 36958817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of Gut Microbiota in Patients with Inflammatory Bowel Disease.
    Ekstedt N; Jamioł-Milc D; Pieczyńska J
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic modelling reveals broad changes in gut microbial metabolism in inflammatory bowel disease patients with dysbiosis.
    Heinken A; Hertel J; Thiele I
    NPJ Syst Biol Appl; 2021 May; 7(1):19. PubMed ID: 33958598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children.
    Martin FP; Su MM; Xie GX; Guiraud SP; Kussmann M; Godin JP; Jia W; Nydegger A
    World J Gastroenterol; 2017 May; 23(20):3643-3654. PubMed ID: 28611517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiome-associated predictors as biomarkers of response to advanced therapies in inflammatory bowel disease: a systematic review.
    Meade S; Liu Chen Kiow J; Massaro C; Kaur G; Squirell E; Bressler B; Lunken G
    Gut Microbes; 2023 Dec; 15(2):2287073. PubMed ID: 38044504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A disturbed metabolite-GPCR axis is associated with microbial dysbiosis in IBD patients: Potential role of GPR109A in macrophages.
    Bauset C; Carda-Diéguez M; Cejudo-Garcés A; Buetas E; Seco-Cervera M; Macias-Ceja DC; Navarro-Vicente F; Esplugues JV; Calatayud S; Mira Á; Ortiz-Masiá D; Barrachina MD; Cosín-Roger J
    Biochim Biophys Acta Mol Basis Dis; 2024 Dec; 1870(8):167489. PubMed ID: 39233260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease.
    Sultan S; El-Mowafy M; Elgaml A; Ahmed TAE; Hassan H; Mottawea W
    Front Physiol; 2021; 12():715506. PubMed ID: 34646151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
    Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.